EU travel regs
This article was originally published in The Rose Sheet
Executive Summary
Airline passengers in the European Union are restricted to carrying limited amounts of liquids, gels and aerosols on-board after the European Commission implements new travel regulations Nov. 6. The rules mirror those adopted by U.S. authorities in late September (1"The Rose Sheet" Oct. 2, 2006, In Brief). According to the EU regs, passengers may carry individual containers holding up to 100 ml (3.4 oz.) of liquid; all containers must fit into one clear, liter-sized re-sealable plastic bag. Exemptions will be made for medicines and liquid dietary products and for items purchased in the secure pre-boarding area. The new rules apply to all flights departing from airports in the EU, no matter their destination or nationality...
You may also be interested in...
TSA eases carry-on rule
Airline passengers are permitted to carry limited amounts of liquids, gels and aerosols on flights after the Federal Transportation Security Administration adjusted its regulations governing carry-on items Sept. 26. According to the new rules, passengers are allowed to carry travel-sized toiletries (sized 3 oz. or less) on-board as long they fit "comfortably" in one quart-size, clear plastic zip-top bag. Passengers also are allowed to carry items purchased in the secure boarding area onto flights. "It is unlikely that further adjustments to the ban on liquids, gels and aerosols will be made in the near future," TSA says, noting it is enhancing "visible and not visible" airport security measures in the meantime. TSA issued a ban on all carry-on liquids, gels and lotions Aug. 10 in response to Britain's arrest of suspects accused of plotting terrorist activity on U.S.-bound flights (1"The Rose Sheet" Aug. 21, 2006, p. 3)...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.